# Tyra Biosciences, Inc. (TYRA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/TYRA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -122.82M | $ -97.56M | $ 5.81M | $ 259.18M |
| 2024 | $ 0 | $ -90.90M | $ -74.04M | $ 6.22M | $ 343.15M |
| 2023 | $ 0 | $ -74.75M | $ -55.05M | $ 6.50M | $ 204.26M |
| 2022 | $ 0 | $ -61.80M | $ -56.80M | $ 2.62M | $ 257.83M |
| 2021 | $ 0 | $ -31.25M | $ -29.01M | $ 1.18M | $ 301.74M |
| 2020 | $ 0 | $ -11.89M | $ -10.29M | $ 142.0K | $ -13.64M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.02 |
| Liabilities / Eq | 0.09 |
| Current Ratio | 14.67 |

## Other views

- [Metrics](https://sponda.capital/en/TYRA.md)
- [Charts](https://sponda.capital/en/TYRA/charts.md)
- [Compare](https://sponda.capital/en/TYRA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.